11:30
#65 Cerebral control of bladder function: the brain-bladder connection
Griffiths D1, Derbyshire S 1, Logue E 1, Stenger V A 1, Resnick N 1 1. University of Pittsburgh
11:37
#66 Urge incontinence as a predictor of institutionalization in an older population
Nuotio M1, Tammela T L1, Luukkaala T1, Jylhä M1 1. University of Tampere
11:45
#67 CORRELATION BETWEEN DETRUSOR AFTER-CONTRACTION AND OVERACTIVE BLADDER SYNDROME, DETRUSOR OVERACTIVITY AND POST-MICTURITION DRIBBLE
D'amico A1, Pesce F1, Rubilotta E1, Sarti A1, Curti P1, Artibani W1 1. Dept. Urology - Policlinico - Verona
11:52
#68 The Diurnal Rhythm of Urine Output and AVP Secretion in Elderly Nocturnal Polyurics, Elderly and Young Controls.
Hvistendahl G M1, Frøkiær J2, Nielsen S3, Djurhuus J C 1 1. Institute of Experimental Clinical Research, University of Aarhus, 2. The Water and Salt Research Center, Institute of Experimental Clinical Research/University of Aarhus, 3. The Water and Salt Center, Institute of Anatomy, University of Aarhus
12:00
#69 Idiopathic detrusor overactivity in women - a 5-10 year longitudinal study of outcomes
Morris A R1, Westbrook J I2, Moore K H1 1. Pelvic Floor Unit, St George Hospital, 2. Department of Health Informatics, University of New South Wales
12:07
#70 DOES DETRUSOR OVERACTIVITY EVER CEASE? REPEAT URODYNAMIC TESTING AT 1 TO 9 YEARS.
Blackwell A L1, Moore K H1 1. Pelvic Floor Unit, St George Hospital, Sydney
12:15
#71 Autonomic Response to Stress in Interstitial Cystitis
Lutgendorf S1, Rothrock N1, Hoffmann A1, Zimmerman B1, Latini J1, Kreder K1 1. University of Iowa
12:22
#72 HYPERBARIC OXYGEN FOR TREATMENT OF INTERSTITIAL CYSTITIS: RESULTS OF A PILOT STUDY
van Ophoven A1, Rossbach G1, Oberpenning F1, Hertle L1 1. University of Muenster
12:30
#73 CONTINUOUS INTRAVESICAL INFUSION OF RESINIFERATOXIN BY IN SITU DRUG DELIVERY SYSTEM TO TREAT INTERSTITIAL CYSTITIS: A PILOT STUDY.
Lazzeri M1, Beneforeti P1, Turini D1, Spinelli M2, Malaguti S2, Giardiello G3 1. Department of Urology - S. Chiara Hospital, 2. Spinal Unit - Magenta (Milan), 3. Medtronic - Italy
12:37
#74 CAN MEDICATION PROLONG WARNING TIME?
Cardozo L1, Prescott K2, Serdarevic D2, Skillern L2 1. Urogynaecology Dept, Kings College Hospital, 2. Pfizer, Sandwich
12:45
#75 Evaluation of OAB Treatment and Patient Satisfaction reflecting ‘Real-Life Conditions’ in Urological offices in Austria
Madersbacher H1, Berner L1, Struhal G1, Eisenmenger M1, Neumann M1 1. Austrian Continence Society
12:52
#76 Chronic sacral (S3) nerve stimulation: The effects on nocturia and nocturnal bladder capacity and correlates with supine urodynamics in women with refractory urge urinary incontinence
Bosch R1, Groen J1 1. Erasmus Medical Center